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Abstract: Anthocyanin-rich foods, such as berries, reportedly ameliorate age-related cognitive
deficits in both animals and humans. Despite this, investigation into the mechanisms which underpin
anthocyanin-mediated learning and memory benefits remains relatively limited. The present study
investigates the effects of anthocyanin intake on a spatial working memory paradigm, assessed
via the cross-maze apparatus, and relates behavioural test performance to underlying molecular
mechanisms. Six-week supplementation with pure anthocyanins (2% w/w), administered throughout
the learning phase of the task, improved both spatial and psychomotor performances in aged rats.
Behavioural outputs were accompanied by changes in the expression profile of key proteins integral
to synaptic function/maintenance, with upregulation of dystrophin, protein kinase B (PKB/Akt)
and tyrosine hydroxylase, and downregulation of apoptotic proteins B-cell lymphoma-extra-large
(Bcl-xL) and the phosphorylated rapidly accelerated fibrosarcoma (p-Raf). Separate immunoblot
analysis supported these observations, indicating increased activation of extracellular signal-related
kinase (ERK1), Akt Ser473, mammalian target of rapamycin (mTOR) Ser2448, activity-regulated
cytoskeleton-associated protein (Arc/Arg 3.1) and brain-derived neurotrophic factor (BDNF) in
response to anthocyanin treatment, whilst α-E-catenin, c-Jun N-terminal kinase (JNK1) and p38
protein levels decreased. Together, these findings suggest that purified anthocyanin consumption
enhances spatial learning and motor coordination in aged animals and can be attributed to the
modulation of key synaptic proteins, which support integrity and maintenance of synaptic function.
Keywords: flavonoids; brain; signalling; cognition; neuroprotection
1. Introduction
A significant proportion of neurodegenerative conditions, as well as more generalised
cognitive decline, can be attributed to modifiable lifestyle factors such as diet [1]. Diet has
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been increasingly acknowledged for its impact on brain health and strongly influences age-
related cognitive decline [2], as well as neurodegenerative disease incidence and onset [3].
Diet therefore represents an important means that can be used to support both healthy
ageing and the attenuation of neurological disease risk. Phytochemical constituents such
as flavonoids have emerged over the past decades as key influencers of brain health and
disease and are being avidly investigated in order to determine their neuroprotective
potential [4,5], boosted by their apparent multi-target actions. Epidemiological studies
highlight this potential, with increased total flavonoid consumption positively associated
with improved cognitive and memory function amongst adults [6,7], slower rates of
cognitive decline amongst the elderly [8], and reduced risk of neurodegenerative diseases,
such as Parkinson’s [9] and Alzheimer’s diseases [10,11].
A subgroup of flavonoids known as anthocyanins, water-soluble plant pigments
particularly abundant in berries, have been recognised for their bioactive properties and
are known to influence numerous disease processes. These effects appear to extend to the
brain, with anthocyanins gaining attention for their protective effects against age-related
neurodegeneration and cognitive decline [12,13]. Consistent with these observations, pre-
clinical studies indicate that anthocyanins improve learning and memory across several
mammalian species [13,14], with anthocyanin-rich blueberry intake shown to induce spa-
tial memory improvements in young animals [15,16] and ameliorate age-related cognitive
decline in old animals [17–20]. Current human studies are in agreement with pre-clinical
research findings. Indeed, increased blueberry and strawberry anthocyanin consump-
tion [8,21–25] is associated with improved cognitive functions amongst young healthy
adults [26], whilst cognitive decline and Alzheimer’s dementia risk is reduced amongst el-
derly non-demented adults. Furthermore, dietary intervention studies in humans utilising
anthocyanin-rich plant or food extracts indicate an ability of these dietary components to
improve cognitive performance in older adults [27,28] and in patients with mild cognitive
impairment [29]. Mechanistically, enhancement of neuronal signalling and synaptic plas-
ticity [16,30], neuronal resilience [31], glucose metabolism/insulin resistance [32,33] and
modulation of the microbiota and its subsequent functions [34] have been forwarded as
plausible modes of action; however, further elucidation is required.
Anthocyanins have considerable potential in regard to brain health and disease. We
previously reported that supplementation with pure anthocyanins (2% w/w) for 6 weeks
resulted in an enhancement of spatial working memory in 18-month-old rats. These
behavioural changes coincided with a regional increase of brain derived neurotrophic factor
(BDNF) mRNA expression within the hippocampus, highlighting a potential mechanism of
action attributable to the memory improvements observed in these aged animals [20]. Here,
we extend upon this report by further elucidating the underlying mechanisms of actions
associated with anthocyanin-rich extract, specifically neuronal signalling and synaptic
function/integrity. In contrast to previous investigations in which feeding of animals occurs
during the post-task training period, the present study specifically focusses on a novel
cognitive paradigm aiming at understanding how supplementation with anthocyanin-rich
extract during the cross-maze apparatus task may enhance the learning capabilities of aged
naïve animals (e.g., supplementation is concomitant to task learning in the cross-maze
apparatus).
2. Materials and Methods
2.1. Study Approval
Experimental procedures and protocols were reviewed and approved by the Animal
Welfare and Ethical Review Body (AWERB) and were conducted within the provisions of
the Home Office Animals (Scientific Procedures) Act 1986 (ethical protocol code: 30/4246).
Utmost effort was utilised to prevent suffering and minimize the numbers of animals
required for these experiments.
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2.2. Extraction and Analysis of the Anthocyanins
The anthocyanin fraction was prepared by extracting anthocyanins from blueberries
(Vaccinium corymbosum) giving rise to a pre-purified extract. Briefly, 5 kg of frozen blue-
berries harvested in SCEA Dittmeyer Agricola (Domaine des Myrtilles “le Auqueyres”,
Parentis en Born, France) were first ground and extracted for 2 h under constant stirring in
2.5 L of methanol-trifluoroacetic acid (999:1) at room temperature. After filtration on glass
wool, the residue was extracted a second time as described above and filtrated. The filtrates
were combined and concentrated to 1 L under reduced pressure at 35 ◦C. The residual layer
was then extracted with (6 × 1 L) of methyl tert-butyl ether (MtBE). The MtBE extract was
discarded and the aqueous extract containing anthocyanins was freeze-dried. Enhancement
of its anthocyanins content was achieved by adsorption on Amberlite XAD-7 washed by
H2O-trifluoroacetic acid (999:1), followed by elution with methanol-trifluoroacetic acid
(999:1); this provided 16.3 g of a pre-purified extract. The identification of anthocyanins
was achieved by a combination of liquid chromatography electrospray ionisation tandem
mass spectrometry (LC-ESI-MS/MS) and liquid chromatography tandem nuclear mag-
netic resonance (LC-NMR) analyses as described previously [35]. Liquid Chromatography
tandem mass spectrometry (LC MS/MS) analyses were carried out on a chromatography
apparatus, Agilent 1200 from Agilent Technologies (Santa Clara, CA, USA) coupled to an
Esquire 3000+ ion trap mass spectrometer using an electrospray ionisation (ESI) source
from Bruker Daltonics (Billerica, MA, USA). For LC-NMR analyses, the chromatography
apparatus was similar to that of LC–MS/MS and was coupled to a Bruker AVANCE III
600 MHz spectrometer equipped with a 1H–13C inverse detection flow probe from Bruker
BioSpin (Rheinstetten, Germany) (Table S1). Anthocyanin content was estimated at 62.4%
enrichment from calibration curves using appropriate analytical methods [36].
2.3. Animals and Dietary Supplementation
Sixteen male Wistar rats aged 16 months at the beginning of the experiments were
purchased from Harlan (Blackthorn, UK). Animals were maintained in a controlled envi-
ronment (21 ± 2 ◦C), humidity (55 ± 10%), a standard light-dark cycle (12 h/12 h) and fed
ad libitum on a standard chow diet (RM3-P, Special Diet Services, Essex, UK). Following
2 weeks of acclimatisation, animals were then pseudo-randomly assigned to 2 groups
(n = 8 per group, starting body weight: 512 ± 37 g) based on their baseline spatial working
memory correct choice scores and matched across all eight animals per group.
Pure anthocyanin extracts obtained as described above were incorporated (2% w/w)
into the standard AIN-76A purified diet for rodents (Research Diets, New Brunswick,
NJ, USA) and made into dry pellets for animal consumption. Both interventions used
were analytically well characterised, isocaloric and macro- and micronutrient-matched
(Table S2). Body weight and food intake were recorded twice a week. Immediately after
acclimatization, naïve rats were fed either the anthocyanin diet or the control for a duration
of 6 weeks. Spatial working memory was assessed at the beginning and end of the feeding
period as described below.
Following the 6-week intervention, an overdose of sodium pentobarbital (150 mg/Kg,
i.p) was administered. Blood was drawn via cardiac puncture and centrifugated (10 min,
1300× g, room temperature) to obtain sera, whilst ice-cold saline (100 mL) containing
10 U/mL of sodium heparin was transcardially perfused prior to isolation of brains. All
samples were snap-frozen in liquid nitrogen and stored at −80 ◦C until further analysis.
2.4. Spatial Working Memory Testing
2.4.1. Habituation and Shaping Sessions
Rats were tested in a cross-maze apparatus as described previously [17,20]. During the
course of the habituation period the rats were maintained in a food-deprived state. Prior to
experimental testing and supplementation, animals were subjected to 6 weeks of shaping
sessions (2 × shaping sessions per week and 6 × trials per session), to ensure animals
could reliably obtain rewards from maze arms. In each trial animals were required to enter
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an open goal arm and collect a reward pellet from the food well (entry to the al-ternate
goal arm was restricted). The ‘open’ goal arm was varied between trials according to a
pseudorandom schedule (Supplementary Figure S1).
2.4.2. Alternation Task
Immediately after habituation (baseline) and completion of the 6-week shaping ses-
sions, test sessions were conducted. A pseudo-random sequence of correct arm choices,
as well as the starting arm choice, was selected for each test session. Rats (unfasted state)
were subjected to testing sessions as previously described [17]. Briefly, animals received 8
trials per test session with a 5 min intertrial interval, with each trial consisting of a sample
and choice phase (ref previous paper). Upon completion of a trial the animal was returned
to its cage for 5 min before commencing the next trial. Accuracy and latency to make a
choice were measured for each trial. Ethanol solution with a 50% concentration was used
to clean the maze after each trial to remove olfactory cues.
2.5. Accelerating Rotarod
Fine motor coordination, balance, and resistance to fatigue were quantitated by mea-
suring the amount of time an animal could remain standing on a rotating, accelerating Rota
Rod (Harvard Apparatus, Cambridge, Cambridgeshire, UK). The rod consists of a drum,
60 mm in diameter, which could be varied for rotational speed. Each rat was individually
placed upon the rod which was initially set at 2 rpms. Once the animal maintained its
grip/orientation without assistance, the rod steadily accelerated in increments for five
minutes (2 rpms per 30 s) until 20 rpms was reached. Time spent upon the apparatus
(maximum = 300 s) was recorded.
2.6. Antibody Microarray
The Panorama Antibody Microarray Cell Signalling Kit (Sigma-Aldrich, Amersham,
UK) was used as described previously [37]. Statistical analysis was conducted on biological
replicates and significantly modulated protein expression in the hippocampus is reported
in Supplementary Table S4.
2.7. Western Immunoblotting
Dissected brain regions were homogenized on ice with a glass homogenizer (10 strokes)
using Tris (50 mM), Triton X-100 (0.1%), NaCl (150 mM) and EGTA/EDTA (2 mM); pH 7.4,
containing mammalian protease inhibitor cocktail (1:100 dilution), sodium pyrophosphate
(1 mM), phenylmethylsulfonyl fluoride (10 µg/mL), sodium vanadate (1 mM) and sodium
fluoride (50 mM). Homogenates were left on ice for 45 min before centrifugation at 1000× g
for 5 min at 4 ◦C to remove unbroken cell debris and nuclei. Protein concentration in the
supernatants was determined by the Pierce BCA assay (Thermofisher, Loughborough, UK).
For analysis of proteins by Western immunoblotting, samples were incubated for 5 min at
95 ◦C in boiling buffer (final conc. 62.5 mM Tris, pH 6.8, 2% sodium dodecyl sulfate, 5%
2-mercaptoethanol, 10% glycerol and 0.0025% bromophenol blue).
The processed samples (20–40 µg/lane) were loaded and run on a 9–12% SDS-
polyacrylamide gel and after separation transferred to nitrocellulose membranes (Hybond-
ECL; Sigma-Aldrich, Amersham, UK) by semi-dry electroblotting (1.5 mA/cm2). The nitro-
cellulose membrane was then blocked (20 mM Tris, pH 7.5, 150 mM NaCl; Tris-buffered
saline (TBS) containing 4% (w/v) skimmed milk powder) for 45 min at room temperature
and washed twice for 5 min in TBS supplemented with 0.05% (v/v) Tween 20 (TTBS).
Blots were then incubated with either anti-phospho-p44/42 MAPK (Erk1/2) (Thr 202/Tyr
204) pAb (1:1000 dilution), anti ERK1/ERK2 pAb (1:1000), anti-phospho-SAPK/JNK (Thr
183/Tyr 185) pAb (1:1000), anti-SAPK/JNK (1:1000) pAb, anti-phospho-p38 MAPK (Thr
180/Tyr 182) pAb (1:1000), anti p38 MAPK pAb (1:1000), anti-phospho-Akt (Ser 473) pAb
(1:1000), anti-Akt pAb (1:1000), anti-phospho-mTOR (Ser 2448) pAb (1:1000), anti-mTOR
pAb (1:1000), anti-Arc/Arg3.1 pAb (1:1000), anti-BDNF pAb (1:1000), anti-α-E-catenin
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pAb (1:500) or anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH) pAb (1:5000),
in TTBS containing 1% (w/v) skimmed milk powder (antibody buffer) overnight at room
temperature on a three dimensional rocking table. After this, blots were washed twice
for 10 min in TTBS and incubated with goat anti-rabbit IgG conjugated to HRP (1:1000
dilution) for 60 min. Blots were given a final wash twice for 10 min in TTBS rinsed in TBS
and covered in enhanced chemiluminescence reagent for 1–2 min. Images were devel-
oped and band intensities were analysed using Image J software (version 1.52p, National
Institutes of Health, Bethesda, MD, USA) [38]. Molecular weight markers were used for
band identification (MW 27,000–180,000 and MW 6500–45,000 (Sigma Aldrich, Amersham,
UK) and were run in parallel with the samples. Equal loading and efficient transfer were
confirmed through Ponceau Red staining.
2.8. Statistical Analysis
All behavioural data were subjected to two-way analysis of variance for repeated
measures with group (placebo, anthocyanins) and time (0, 6 weeks) as main factors. The p
values were corrected for multiple testing by Benjamini–Hochberg correction to control
for false discovery rate. For the protein array data evaluation, statistics and differen-
tially regulated protein identification were carried out using the Perseus software v1.6.1.3
(http://www.perseus-framework.org (accessed on 18 December 2019); Max Planck Insti-
tute of Biochemistry, Martinsried, Planegg, Germany). The protein log2-fold changes were
evaluated by using the comparison of absorbance between the control and treated experi-
mental groups. The two samples test was applied, with the following criteria: student’s
t-test, S0 value of 0 on both sides, permutation-based false discovery rate (FDR) value of
0.05. Gene Ontology analyses and overexpressed test (Fisher’s exact, p value < 0.05 and
FDR < 0.1), related to Rattus norvegicus reference database, were performed by Panther Clas-
sification System (www.pantherdb.org, accessed on 18 December 2019). For the Western
immunoblotting data, the statistical evaluation of the results was performed by unpaired
t-test. All statistical analyses unless otherwise stated were conducted using GraphPad
Prism version 8 (GraphPad Software, San Diego, CA, USA).
3. Results
3.1. Weight and Food Intake
A significant increase in body weight was observed over the time course of the
experiment (F (1, 16) = 10.74; p = 0.0047) and was similar across both experimental groups
(control: 25.1 ± 18.3 g; anthocyanin: 27.9 ± 18.0 g), with no significant effect of treatment
established (F (1, 16) = 0.4604; p = 0.5071). In addition, there was no significant change
in food intake established for either of the two dietary groups (p > 0.05), with control
and anthocyanin group consuming on average 28.2 g and 30.6 g food/day, respectively.
Average anthocyanin consumption was determined to be 6.12 mg/day/rat.
3.2. Shaping Sessions
Immediately after the 2-week habituation period, a test session aiming to assess the
animals’ spatial working memory was started. As anticipated, untrained naive animals per-
formed below chance (e.g., 4 out of 8 trials) at baseline with the number of scores reaching
on average 2.7 ± 1.5 correct choices. Animals were split into two balanced groups according
to baseline performance, forming group 1 (2.6 ± 1.8 correct choices) which were allocated
placebo and group 2 (2.8 ± 1.4 correct choices) which were allocated the anthocyanin
treatment (p > 0.05). Thereafter and whilst being fed either the control or anthocyanin-rich
extract, animals were habituated to the rules of the cross-maze through successive training
sessions denominated thereafter shaping sessions for a period of 6 weeks. There was a
highly significant effect of time (F (5, 153) = 12.80, p < 0.0001) and treatment (F (1, 34) = 4.892,
p = 0.0338), but no significant interaction (F (5, 153) = 1.584, p = 0.1677) over the 6-week pe-
riod indicating that the animals learned the rules of the task, with anthocyanin-rich extract
fed animals performing better than the control fed animals. Post-hoc analysis indicated a
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trend towards significant improvements in task realisation (in relation to control) by the
fourth week of supplementation with the anthocyanin-rich extract (p = 0.0544), with the
effect maintained throughout the remainder of the intervention period (week 5, p < 0.05
and week 6, p < 0.01) (Figure 1A).
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Figure 1. (A) Effect of anthocyanin (ACN) supplementation on learning the cross-maze rules during
the shaping sessions. Results are presented as percentage ± SEM of task realisation (n = 8). Two-way
ANOVA indicated a significant time (F (5, 153) = 12.80, p < 0.0001) and treatment (F (1, 34) = 4.892,
p = 0.0338) but no significant interaction (F (5, 153) = 1.584, p = 0.1677) imp ct on ta k realisation.
B ferroni post-hoc test indicated a greater effect of thocyanins on completing the task versus
control treatment following 6 weeks of shaping sessions. * p < 0.05, ** p < 0.01, *** p < 0.001.
(B) Effect of anthocyanin (ACN) supplementation on spatial memory performance measured as
choice accuracy (number of correct choices) in a T maze apparatus. Maximum score is eight correct
choices. Results are presented as means ± SEM (n = 8). Two-way ANOVA indicated a significant time
effect (F (1, 14) = 39.09, p < 0.0001) and interaction (F (1, 14) = 6.067, p = 0.0273), but no significant
effect of treatment F (1, 14) = 2.465, p = 0.1387) on overall cognitive performance. Bonferroni
post-hoc test analysis indicated a greater effect of the anthocyanin-rich extract versus control on
spatial working memory following 6 weeks of shaping sessions. (C) Effect of anthocyanin (ACN)
supplementation on latency time to fall from the rotating rod. Results are presented as means ± SEM
(n = 8). The latency time to fall was significantly affected by time (F (1, 14) = 14.72, p = 0.0024) but not
by treatment (F (1, 12) = 0.2566, p = 0.6217). No interaction between treatment and time was observed
(F (1, 12) = 0.7910, p = 0.3913). Subsequent post-hoc analysis revealed that anthocyanin fed animals
maintained a better dynamic equilibrium (p = 0.0017) compared to those fed a control diet (p = 0.1183)
following 6 weeks of supplementation.
3.3. Spatial Working Memory
Six weeks of shaping sessions in the cross-maze apparatus had a significant impact
on working spatial memory. Indeed, a highly significant effect of time (F (1, 14) = 39.09,
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p < 0.0001) and interaction (F (1, 14) = 6.067, p = 0.0273), but no significant effect of treatment
F (1, 14) = 2.465, p = 0.1387) was observed on the animals’ overall cognitive performance. As
anticipated, control animals significantly improved by 1.5 ± 0.5-fold their working spatial
memory following 6-week shaping sessions (p < 0.05), indicating they had learnt/acquired
the rules of the cross-maze apparatus. However, feeding anthocyanin-rich extract for
6 weeks resulted in an improvement of 2.1 ± 0.3-fold (p < 0.001) of the overall cognitive
performance of the animals in the alternation task of the spatial working memory test
(Figure 1B). Animals receiving the anthocyanin-rich extract performed on average 0.7 ± 0.5-
fold better than the control fed animals (p = 0.00024) at 6 weeks. Time taken to complete
the task was also measured in addition to the choice accuracy, revealing no significant
differences among groups during the acquisition of the task (not shown).
3.4. Motor Skills
As a measure of general motor skills, the dynamic equilibrium of the animals was
tested on a rotating rod, and data are presented as latency time to fall. The latency to
fall was significantly affected by time (F (1, 14) = 14.72, p = 0.0024) but not by treatment
(F (1, 12) = 0.2566, p = 0.6217), nor by the time and treatment interaction (F (1, 12) = 0.7910,
p = 0.3913). Subsequent post-hoc analysis revealed that treatment with anthocyanin-
rich extract improved dynamic equilibrium (p = 0.0017) compared with placebo control
(p = 0.1183) following 6 weeks of supplementation (Figure 1C). No impact of time nor
treatment was observed for the rotating speed of the rod (not shown).
3.5. Hippocampal Protein Expression
An antibody microarray was employed in these experiments as it represents a pow-
erful tool for examining the abundance of numerous large proteins simultaneously. The
expression profile of hippocampal proteins involved in signal transduction, neuroplasticity,
apoptosis and cell cycle regulation was found to be significantly modulated (p < 0.05)
following 6 weeks’ intake of anthocyanin-rich extract compared to the iso-caloric control.
The protein array analyses resulted in more than 200 quantified proteins (Supplementary
Table S1). Figure 2 depicts a volcano plot of proteins quantified by the protein array ap-
proach. The overexpressed proteins are highlighted in red, on the right of graph. The
under-expressed proteins are showed in green, on the left of the graph.
Proteins of particular interest identified in the protein array were confirmed via West-
ern Blot analyses (blue circle in the graph). ERK1 protein was 1.5–2-fold increased (p < 0.01)
in the anthocyanin treated group whilst ERK2 proteins were unaffected (Figure 3A). In
contrast to ERK proteins, α-E-catenin (p < 0.05), JNK1 (p < 0.001) and p38 (p > 0.05, ns)
protein levels were down regulated following anthocyanin intake (Figure 3B–D).
Probing further proteins involved in synaptic plasticity maintenance, we identified
Akt Ser 473 (p < 0.05), mTOR Ser 2448 (p < 0.01), Arc/Arg 3.1 (p < 0.05) and BDNF (p < 0.05)
to be positively modulated by the anthocyanin-rich extract treatment (Figure 4A–C).
Figure 5 presents the Gene Ontology enrichment of protein class and biological process
terms. The differentially expressed proteins were enriched in several protein classes, such as
transferase, cell adhesion molecule and signalling molecule. Overexpression analyses were
performed using the Panther Gene Ontology Overexpression Test (Pathway) and the results
are presented in Supplementary Table S5. The main enriched pathways were: interferon-
gamma signalling pathway, the Janus kinase (JAK)-signal transducer and activator of
transcription (STAT) signalling pathway, Toll-like receptor signalling pathway, Alzheimer’s
disease-amyloid secretase pathway, rat sarcoma virus (RAS) pathway, B cell activation,
Gastrin and cholecystokinin receptors (CCKR) signalling map, oxidative stress response.
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(20–40 µg protein) were immunoblotted with an ibodies that specifically recogni e (A) phospho-
Ak Ser 473, total Akt; (B) phospho mTOR Ser 2448, total mTOR amd (C) Arc/Arg 3.1, BDNF and
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Antioxidants 2021, 10, 1235 10 of 14
Antioxidants 2021, 10, x FOR PEER REVIEW 10 of 15 
 
Results (phospho/total ratio for Akt Ser473, mTOR Ser 2448; protein/GAPDH ratio for Arc/Arg3.1 
and BDNF) are presented as means ± SEM (n = 6). Band intensities were determined by densitomet-
ric analysis using Fiji Image J. ** p < 0.01; * p < 0.05: indicate significant differences versus control. 
CTL = control; ACN = anthocyanins. 
Figure 5 presents the Gene Ontology enrichment of protein class and biological pro-
cess terms. The differentially expressed proteins were enriched in several protein classes, 
such as transferase, cell adhesion molecule and signalling molecule. Overexpression anal-
yses were performed using the Panther Gene Ontology Overexpression Test (Pathway) 
and the results are presented in Supplementary Table S5. The main enriched pathways 
were: interferon-gamma signalling pathway, the Janus kinase (JAK)-signal transducer 
and activator of transcription (STAT) signalling pathway, Toll-like receptor signalling 
pathway, Alzheimer’s disease-amyloid secretase pathway, rat sarcoma virus (RAS) path-
way, B cell activation, Gastrin and cholecystokinin receptors (CCKR) signalling map, ox-




Figure 5. Pie chart of Gene Ontology enrichment of biological process (A) and protein class (B) terms. 
4. Discussion 
Anthocyanin-rich foods (specifically blueberries and strawberries) have been shown 
to be effective at reversing age-related deficits in spatial memory and can enhance differ-
ent aspects of synaptic plasticity [19,39,40], a process severely affected by ageing [41,42]. 
For example, a 2% (w/w) blueberry diet significantly improved spatial working memory 
through activation of the ERK-CREB-BDNF pathway, an important modulatory pathway 
of synaptic plasticity [17]. Furthermore, supplementation with pure anthocyanins for 6 
weeks at levels similar to that found in blueberry (2% w/w) resulted in an enhancement of 
spatial memory in 18-month-old rats [20]. The improvement in spatial memory induced 
by the anthocyanin was equal to that induced by whole blueberry, suggesting anthocya-
nins are principally responsible for efficacy of the whole fruit in vivo. Whilst most studies 
to date have focussed on memory consolidation and retrieval in ageing models, the pre-
sent study investigated the impact of chronic consumption of anthocyanin extract on the 
learning phase of the spatial working memory paradigm, and therefore assessed learning 
capacity of 16-months old rats. Our results demonstrate that over the course of the 6-week 
Figure 5. Pie chart of Gene Ontology enrichment of biological process (A) and protein class (B) terms.
4. Discussion
Anthocyanin-rich foods (specifically blueberries and strawberries) have been shown
to be effective at reversing age-related deficits in spatial memory and can enhance different
aspects of synaptic plasticity [19,39,40], a process severely aff cted by ageing [41,42]. For
example, a 2% (w/w) blue erry diet significantly improved spati l working memory
through activation of the ERK-CREB-BDNF pathway, n important modulatory pathway of
synaptic plasticity [17]. Furthermor , supplementation wi h pure anthocy ins for 6 weeks
at lev ls similar to that found in bl eberry (2% w/w) resulted in an enhancement of spatial
memory in 18-month-old rats [20]. The improv ment in spatial memory induced by the
anthocyanin was equal to that induced by whole blueberry, suggesting anthocyanins are
princip lly responsible for efficacy of the whole fruit in vivo. Whilst most studies to date
have focussed on memory consolidation and re riev l in ageing models, the pres nt study
inv s igated the imp ct of chronic consumpt on of anthocyanin extract on the learni g
phase of the spatial working memory paradigm, and therefore assessed l rning capacity
of 16-months old rats. Our results demonstrate that over the course of the 6-week shaping
phase, animals receiving the anthocyanin extract performed better in the cross-maze
apparatus, indicating an enhancement of learning capabilities. In addition, performance in
the cross-maze apparatus was independent of the improvement of motor skills, indicating
a clear cognitive impact of the anthocyanin treatment.
The enhancement of spatial memory performance induced by the anthocyanin-rich
extract was supported by subsequent molecular analysis, which revealed a significant
modulation of hippocampal protein expression that likely underpins these behavioural
effects. These proteins are involved in metabolic, immune and cell adhesion molecule pro-
cesses. Previously we have observed that BDNF, a major regulator of synaptic transmission
and plasticity at adult synapses [43], is activated through the ERK-CREB-BDNF pathway
and may mediate the influence of anthocyanin-rich foods on spatial memory [16,17,20].
In agreement with these results, we again observed a significant modulation of ERK1/2
and BDNF by the anthocyanin-rich extract treatment. The concomitant increase in BDNF
observed in our anthocyanin-rich diet-supplemented aged animals may be responsible for
the enhancements in spatial working memory. Such improvement may be mediated in
part through the activation of the PI3K/Akt pathway, the activation of mTOR through the
Antioxidants 2021, 10, 1235 11 of 14
phosphorylation at Ser 2448, along with the subsequent neurotransmitter release in the
synaptic cleft [44]. In corroboration with these proposed mechanisms, increased phospho-
rylation of both Akt Ser 473 and its downstream target mTOR Ser 2448 was established in
the aged anthocyanin treated animals. Further downstream, hippocampal protein levels of
activity-regulated cytoskeleton-associated protein Arc/Arg3.1, which has been associated
with memory improvements and long-term potentiation (LTP), mirrored the level of both
BDNF and ERK1/2. Such findings therefore suggest that the increase in Arc/Arg3.1 may
be under the regulatory control of both BDNF and ERK1/2 in the hippocampus.
Anthocyanin-rich extract treatment upregulated the expression of a range of cytoskele-
tal proteins in the hippocampus, including dystrophin, plakoglobin, vinculin, microtubule
associated protein 1 (MAP1b) and spectrin. Such proteins have integral roles at neuronal
membranes where they support learning and memory processes [45] and regulate synap-
togenesis [46]. For example, lack of dystrophin in the hippocampus has been reported to
affect cognitive functions [47], spatial memory and long-term potentiation [48]. In addition
to cytoskeleton proteins, anthocyanin intake significantly affected the expression of the
pro-apoptotic caspase-3 and anti-apoptotic proteins, such as Bcl-xL and other members
of the Bcl-2 family. Although Bcl-xL has been reportedly implicated in Alzheimer’s dis-
ease [49], recent evidence highlights a role for this protein in neurite outgrowth [50,51],
synaptic plasticity [52,53], and mitochondrial bioenergetics [54,55]. Such reductions in
Bcl-xL are therefore likely to promote cell survival [56]. In addition, while proteolytic
caspases and in particular caspase-3 have been implicated in neurodegenerative disorders
and Alzheimer’s disease [57], evidence also suggests that caspase-3 may play alternative
roles which include modulation of synaptic plasticity along with learning and memory
processes [58,59]. Such activation of caspase-3 following anthocyanin intake may therefore
be related to improvement in learning and memory, although further work would be
necessary to validate this hypothesis.
We previously reported similar findings in age-related memory deficit rodents fed
a hydroxybenzoic acid and hydroxycinnamate-rich diet [37]. Such small phenolics may
cross the blood–brain barrier via amino acid transporters [60] and can therefore act directly
on protein signalling. Interestingly, following uptake anthocyanins are extensively metab-
olized by bacterial fermentation and absorption from the colon [61], giving rise to many
degradation products including phenolic, hippuric, phenylacetic, and phenylpropenoic
acids. Alternatively, anthocyanins may also affect the microbiota composition and func-
tion [62], which can then interact with brain function through the gut–brain axis [63].
5. Conclusions
This study indicates that the consumption of anthocyanin-rich extract improves learn-
ing capabilities in aged rats, counteracting spatial memory loss in aged brains, through
the modulation of a number of cell signalling events implicated predominantly in synaptic
plasticity, apoptosis and cytoskeleton remodelling. These processes act synergistically to
maintain the number and strength of synaptic connections in the brain, an essential factor
for efficient memory and cognitive functions.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/antiox10081235/s1, Figure S1: Experimental design, Table S1: Raw data protein array results,
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and fragment ions) along with 1H-NMR chemical shifts of the anthocyanins detected., Table S3:
Composition of the animal diets, Table S4: Proteins significantly (FDR adjusted p < 0.05) modulated
by the anthocyanins treatment as assessed by the Protein microarray technique, Table S5: Panther
gene Ontology Overexpression Test (Pathway).
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